BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19464163)

  • 1. Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
    Tuthill M; Pell R; Guiliani R; Lim A; Gudi M; Contractor KB; Lewis JS; Coombes RC; Stebbing J
    Eur J Cancer; 2009 Aug; 45(12):2146-9. PubMed ID: 19464163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of surgery with improved survival in stage IV breast cancer patients.
    Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
    Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis.
    McLemore EC; Pockaj BA; Reynolds C; Gray RJ; Hernandez JL; Grant CS; Donohue JH
    Ann Surg Oncol; 2005 Nov; 12(11):886-94. PubMed ID: 16177864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
    Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity, outcome and challenges of breast cancer in Nigeria.
    Adesunkanmi AR; Lawal OO; Adelusola KA; Durosimi MA
    Breast; 2006 Jun; 15(3):399-409. PubMed ID: 16085418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
    Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
    Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.
    Williams SA; Ehlers RA; Hunt KK; Yi M; Kuerer HM; Singletary SE; Ross MI; Feig BW; Symmans WF; Meric-Bernstam F
    Cancer; 2007 Aug; 110(4):731-7. PubMed ID: 17582626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer with macroscopic peritoneal involvement--clinical challenges and consequences.
    Sigurdsson HK; Kørner H; Dahl O; Skarstein A; Søreide JA;
    Colorectal Dis; 2009 Oct; 11(8):838-44. PubMed ID: 19175632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
    Chagpar AB; McMasters KM; Sahoo S; Edwards MJ
    Surgery; 2009 Oct; 146(4):561-7; discussion 567-8. PubMed ID: 19789013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy.
    Liu GF; Yang Q; Haffty BG; Moran MS
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1304-8. PubMed ID: 19386432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.
    Mhuircheartaigh JN; Curran C; Hennessy E; Kerin MJ
    Br J Surg; 2008 Jul; 95(7):827-33. PubMed ID: 18498127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of synchronous invasive lobular breast carcinoma and poorly differentiated ovarian carcinoma in a single peritoneal deposit.
    Syed R; Nazir SA; Lwin KY; Bose P; Evans P; Choji K
    Oncology; 2007; 73(1-2):136-40. PubMed ID: 18337627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men with breast cancer have same disease-specific and event-free survival as women.
    Marchal F; Salou M; Marchal C; Lesur A; Desandes E
    Ann Surg Oncol; 2009 Apr; 16(4):972-8. PubMed ID: 19184227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer.
    Katoh H; Yamashita K; Sato T; Ozawa H; Nakamura T; Watanabe M
    Br J Surg; 2009 Jul; 96(7):769-77. PubMed ID: 19526618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneal metastasis of breast cancer].
    Firescu D; Ardeleanu V; Rebegea Paraschiv L; Ceauşu M; Ceauşu MZ
    Chirurgia (Bucur); 2009; 104(5):631-5. PubMed ID: 19943567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
    Lai YL; Mau BL; Cheng WH; Chen HM; Chiu HH; Tzen CY
    Ann Surg Oncol; 2008 Apr; 15(4):1064-9. PubMed ID: 18183466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is pleomorphic lobular carcinoma really a distinct clinical entity?
    Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
    J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.